Abstract A study with varying dietary inclusion levels (1, 5, 10, 15 and 20 g kg -1 ) of docosahexaenoic acid (DHA; 22:6n-3) was conducted with post-smolt (111 ± 2.6 g; mean ± S.) Atlantic salmon (Salmo salar) over a 9-week period. In addition to the series of DHA inclusion levels, the study included further diets that had DHA at 10 g kg -1 in combination with either eicosapentaenoic acid (EPA; 20:5n-3) or arachidonic acid (ARA; 20:4n-6), both also included at 10 g kg -1 . An additional treatment with both EPA and DHA included at 5 g kg -1 (total of 10 g kg -1 long-chain polyunsaturated fatty acids, LC-PUFA) was also included. After a 9-week feeding period, fish were weighed, and carcass, blood and tissue samples collected. A minor improvement in growth was seen with increasing inclusion of DHA. However, the addition of EPA further improved growth response while addition of ARA had no effect on growth. As with most lipid studies, the fatty acid composition of the whole body lipids generally reflected that of the diets. However, there were notable exceptions to this, and these implicate some interactions among the different LC-PUFA in terms of the fatty acid biochemistry in this species. At very low inclusion levels, DHA retention was substantially higher (*250 %) than that at all other inclusion levels (31-58 %). The inclusion of EPA in the diet also had a positive effect on the retention efficiency of DHA. However, EPA retention was highly variable and at low DHA inclusion levels there was a net loss of EPA as this fatty acid was most likely elongated to produce DHA, consistent with increased DHA retention with additional EPA in the diet. Retention of DPA (22:5n-3) was high at low levels of DHA, but diminished with increasing DHA inclusion, similar to that seen with DHA retention. The addition of EPA to the diet resulted in a substantial increase in the efficiency of DPA retention; the inclusion of ARA had the opposite effect. Retention of ARA was unaffected by DHA inclusion, but the addition of either EPA or ARA to the diet resulted in a substantial reduction in the efficiency of ARA retention. No effects of dietary treatment were noted on the retention of either linolenic (18:3n-3) or linoleic (18:2n-6) acids. When the total n-3 LC-PUFA content of the diet was the same but consisted of either DHA alone or as a combination of EPA plus DHA, the performance effects were similar.
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Introduction
Most aquatic species have some form of requirement for long-chain polyunsaturated fatty acids (LC-PUFA) as essential dietary nutrients. However, which specific fatty acid (n-3 or n-6, long-chain or C18) satisfies those requirements, their concentration in the diet, and how the value of a specific fatty acid is influenced by the presence of other dietary fatty acids appears to vary markedly among species (reviewed by Glencross 2009) . It is generally considered that marine species have a higher, or more defined requirement, for the LC-PUFA docosahexaenoic acid (DHA; 22:6n-3) and/ or eicosapentaenoic acid (EPA; 20:5n-3), while diadromous species have a lower requirement, and some freshwater species appear to have no requirement at all for LC-PUFA (Bell et al. 1986; Castell et al. 1994; Tocher 2003; Glencross 2009 ). The absence of LC-PUFA from the diet of many fish species often results in signs of 'deficiency', which has an aetiology of reduced growth rate, increased mortality, erosion of the caudal fin, myocarditis and shock syndrome (Castell et al. 1972a; Ruyter et al. 2000a) . There is also an apparent increased sensitivity of the fish to stressful situations (Castell et al. 1972a, b) .
Unlike most marine species, salmonids have been shown to have the ability to elongate and desaturate alinolenic acid (LNA; 18:3n-3) to produce EPA and DHA (Castell et al. 1972a, b; Thomassen et al. 2012) . The dietary requirement of salmonids for n-3 LC-PUFA has been reported to range from 10 to 25 g kg -1 of the diet depending on species and experimental conditions (reviewed by Glencross 2009 ). The early studies of Castell et al. (1972a, b) with rainbow trout (Oncorhynchus mykiss) focussed on the requirement for linoleic acid (LOA; 18:2n-6) or LNA and found that growth was significantly better with LNA over LOA or a polyunsaturated fatty acid (PUFA)-deficient diet. However, the value of LNA as an 'essential nutrient' for trout exists only because it has significant ability to desaturate and elongate LNA to the biologically active LC-PUFA, EPA and DHA (Castell et al. 1972a, b; Thomassen et al. 2012) . These studies also demonstrated that there was no requirement for n-6 PUFA by rainbow trout (Castell et al. 1972a, b) , though this notion was later challenged by the assertion that trout may require small amounts of n-6, specifically arachidonic acid (ARA; 20:4n-6), for prostaglandin and leukotriene synthesis (Henderson et al. 1985; Villalta et al. 2008) .
Although the early work of Castell et al. (1972a, b) defined a requirement for n-3 PUFA, it was a series of studies on Atlantic salmon fry in freshwater undertaken by Ruyter et al. (2000a) that went on to examine the quantitative and qualitative EFA requirements for LOA, LNA and EPA ? DHA. It was shown that inclusion of LNA and EPA ? DHA both provided significant benefits to the fish. However, in the work by Ruyter et al. (2000a) , the roles of the LC-PUFA of DHA and EPA were only examined in combination. Recent studies with barramundi (Lates calcarifer) have reported discrete effects of DHA alone or in the presence of EPA and verified the synergistic importance of both fatty acids (Glencross and Rutherford 2011) . Additionally, the influence of the n-6 LC-PUFA, ARA, has also been assessed and showed some contrasting effects to that observed with the inclusion of EPA, reflecting the competing roles that these fatty acids have in the pathways for eicosanoid synthesis (Terano et al. 1986; Garg et al. 1990; Garg and Li 1994; Bell et al. 1995) .
The present study therefore examined the inclusion of incremental levels of dietary DHA on the performance attributes of post-smolt Atlantic salmon and the differential utilisztion of different LC-PUFA by this species. A series of additional treatments were included in the study to examine the effect of EPA (at two inclusion levels) and ARA on the response of this species to DHA. In addition to growth performance, it was hypothesized that many dietary effects would be subclinical, and therefore, a range of biochemical, compositional and health studies were also included to elucidate the specific influences of DHA and possible interactions with other key LC-PUFA in the diet.
Materials and methods

Diet manufacture and management
A single basal diet was formulated to provide protein and lipid at 500 and 200 g kg -1 diet at a gross energy level of 22.0 MJ kg -1 (estimated digestible protein and energy of 450 and 19.5 MJ kg -1 , respectively). Of the dietary lipid, 185 g kg -1 was vacuum-infused post-extrusion and it was at this point that the different treatments were made by infusing different oil blends. To produce the basal diet pellets, the dry ingredients were first blended in a series of batches using a 60-L upright Hobart mixer (HL600, Hobart, Pinkenba, QLD, Australia), to produce a single combined 130-kg batch of basal mash that was extruded using the same operational parameters for consistency. The mash was pelletized using a laboratoryscale, twin-screw extruder with intermeshing, co-rotating screws (MPF24:25, Baker Perkins, Peterborough, United Kingdom). The resultant pellets produced through a 4-mm Ø die were cut into 6-8 mm lengths using a twobladed variable speed cutter and collected on aluminium oven trays (650 9 450 9 25 mm, length 9 width 9 depth). Approximately 3-kg lots were collected on each tray and dried at 60°C for 12 h in a fan-forced drying oven.
A series of five DHA oil treatments were created by blending different oils including a purified algalderived (Crypthecodinium sp.) DHA oil source (DHASCO) and a blend of clarified butterfat and olive oil (Table 1) . Three additional treatments were included to examine the interaction effects from the inclusion of EPA or ARA. For the EPA treatments, anchovy oil containing both EPA and DHA in similar amounts was used to provide two treatments, with dietary inclusion levels of either 10 or 5 g kg -1 each of EPA and DHA produced. The ARA treatment was similar to the former EPA treatment, with inclusion levels of 10 g kg -1 each of ARA (provided by ARASCO) and DHA (Table 1) . Compositional analysis of all ingredients (Table 2 ) and diets (Table 3) is provided. Once each of the oil blends was prepared, they were warmed and then thoroughly mixed before being applied using vacuum coating. Dry uncoated pellets were placed in a mixer (Hobart, Sydney, Australia) and the prescribed allocation of oil blend applied while mixing, after which the bowl was sealed with a Perspex lid and a vacuum applied. Once all visible signs of air escaping from the pellets had ceased, the vacuum chamber was re-equilibrated to atmospheric pressure and the oil infused into the pellet.
Fish management
Pre-smolt Atlantic salmon were sourced from the Howietoun fish hatchery (Bannockburn, Scotland) and transferred to the Marine Environmental Research Laboratory (MERL, Machrihanish, Argyll, Scotland) . At MERL, the fish were allocated to two 10,000-L seawater tanks and on-grown to 110.9 ± 2.6 g (mean ± SD) prior to the experiment. The fish were weighed on an electronic toploading balance to 0.5 g accuracy and 20 fish allocated to each of 24 9 500 L tanks. The experiment was conducted in a flow-through, ambient water temperature, 24-tank array. Water temperature was 14.0 ± 0.8°C (mean ± SD) and dissolved oxygen was at 7.8 ± 0.6 mg L -1
(mean ± SD) for the duration of the 62-day experiment. Three replicates (tanks of 20 fish) were used for each treatment. B3, 25 g; vitamin B5, 8.3; vitamin B6, 2.0 g; vitamin B9, 0.8; vitamin B12, 0.005 g; biotin, 0.17 g; vitamin C, 75 g; choline, 166.7 g; inositol, 58.3 g; ethoxyquin, 20 .8 g; copper, 2.5 g; ferrous iron, 10.0 g; magnesium, 16.6 g; manganese, 15.0 g; zinc, 25.0 g During the experiment, feeds were provided on a restricted pair-wise feeding regime with uneaten feed collected to accurately determine feed intake per tank (Helland et al. 1996) . A correction factor was applied to recovered uneaten pellets to account for soluble losses incurred between feeding and collection to improve accuracy of feed intake assessment. The initial restrictive rations were estimated based on 80 % of the feed intake per fish in the week leading up to the trial. Subject to all rations being consumed by each tank, the ration allocations were incrementally increased uniformly across all treatments by 0.25 g fish -1 each week from a base allocation of 1.0 g fish -1
. Total feed fed per fish is presented in Tables 4 and 5 .
Sample preparation and analysis
At the beginning of the study, six fish representative of the initial population were euthanized, dried of residual surface moisture and frozen for subsequent compositional analysis in three lots of two fish. At the end of the experiment, after final weighing, five fish from each tank were similarly sampled and frozen for whole body compositional analysis. The fish from each tank were minced together after defrosting and a sample taken for dry matter analysis and another frozen prior to being freeze-dried. The freeze-dried whole fish samples were milled to a fine powder before being analysed for dry matter, nitrogen (protein), ash, total lipid content and fatty acid compositions. Blood samples (*10 mL total) were collected from the caudal vein of an additional two fish per tank and pooled within a single Falcon TM tube, containing 100 IU of lithium heparin. About half the blood was transferred to three Eppendorf TM tubes before being centrifuged at 1,0009g for *2 min to sediment the erythrocytes and the plasma transferred to a Cryotube TM prior to being frozen in liquid nitrogen. The remaining blood was kept on ice, and haematological analysis performed within 24 h of collection. Clinical biochemical analysis was performed on frozen plasma using an automated chemistry analyser (AU400, Olympus Optical Co. Ltd) using standard assay kits developed for the auto-analyser (Scottish Agricultural College Veterinary Services, Penicuik, Scotland).
The moisture and ash contents of diets and fish were determined according to standard procedures (AOAC 2000) . Dry matter was assessed gravimetrically following oven drying at 105°C for 24 h, and gross ash content was determined gravimetrically after combustion in a muffle furnace at 550°C for 12 h. Energy contents of the diets were measured by bomb calorimetry using a Parr 6200 calorimeter according to standard procedures. Crude protein levels were calculated from the nitrogen content (N 9 6.25) using automated Kjeldahl analysis (Tecator Kjeltec Auto 1030 analyser, Foss, Warrington, UK). Lipid contents were determined gravimetrically after extraction according to Folch et al. (1957) . Fatty acid compositions were determined by gas chromatography of methyl esters essentially according to Christie (2003) . Individual methyl esters were identified by comparison with known standards and by reference to published data (Ackman 1980; Tocher and Harvie 1988) and quantified using Chromcard for Windows (version 1.19).
Physical health assessment
At the end of the study, a series of physical condition features were noted and recorded for each individual a Diets D1, D5, D10, D15 and D20 with regression statistics against formulated DHA inclusion level in the diet b Diets D1, D10, D15, D20, D10A, D10E and D5E with results of ANOVA. Different superscript letters within a row indicate significant differences between means among treatments (P \ 0.05). Absence of any superscripts means that there were no significant effects in that parameter fish within each tank. The incidence of conditions such as pectoral fin erosion, caudal fin reddening or erosion, skin lesions/scale loss, pin-heading and eye malformations was assessed to give a percentage value for each parameter for each tank. A systemic outbreak of amoebic gill disease (AGD) was also present in the facility during the experimental period and was controlled by giving all fish a 2-h freshwater bath treatment once a month. Accordingly, at week 9, an AGD gill score was also given for each fish based on that reported by Taylor et al. (2009) . The scoring for health parameters was carried out by the same person for all fish and at each time point.
Statistical analyses
All figures are mean ± SEM unless otherwise specified. Effects were examined by ANOVA using the software package Statistica (Statsoft Ò , Tulsa, OA, USA). Levels of significance were determined using an LSD planned comparisons test, with critical limits being set at P \ 0.05. Effects of DHA inclusion level were also analysed by regression analysis.
Relative retention (%) of specific fatty acids (DHA, EPA, ARA, DPA, LNA and LOA) was calculated using the mean gross nutrient intake per fish in each tank and the mean gain in mass of specific fatty acids by fish in that tank, over the duration of the study, to give tank-specific values that were then used to derive a treatment mean. The formula used was based on that reported by Glencross et al. (2003) , where FAf is the absolute amount of a specific fatty acid in the fish at the end of the study, and FAi is the absolute amount of that specific fatty acid in the fish at the beginning of the study. FAc is the amount of that specific fatty acid that the fish consumed over the study period, such that: 
Results
Fish growth, feed utilization and survival A significant effect of dietary fatty acid composition on growth (as final weight, weight gain and gain rate) after 9 weeks was observed (Table 4a, b) . No significant differences were observed among the different DHA inclusion levels when analysed using regression (Table 4a ), but fish fed diet D10E had significantly better growth than fish fed the diets with the two lower and the two higher DHA inclusion levels (Table 4b) . Some significant differences in FCR among the treatments were observed. Both of the EPA treatments showed significantly lower FCR than the two lower DHA inclusion levels (D1 and D5). No significant improvements in FCR were noted with increasing DHA inclusion based on regression analysis (Table 4a) . No significant effects of treatment on survival were noted.
Tissue composition and fatty acid retention
The fatty acid composition of fish largely reflected that of the dietary treatments (Table 5 ). There was an increasing percentage of DHA in the tissues of fish fed increasing dietary DHA content. However, the concentration of DHA was typically always marginally higher than that of the diet. Somatic EPA content declined substantially from the initial fish in all treatments and at the end of the experiment represented around 3 % of total fatty acids (Table 5) . Even with the treatment containing a higher level of added EPA, it still only represented 4 % of the total fatty acids. Somatic ARA was low in fish fed all treatments (\1 %) except for fish fed diet D10A where it increased to around 3 % of the total fatty acids in the fish (Table 5) . Total saturated fatty acid content of fish at the end of the experiment was generally very consistent at around 30 % of total fatty acids (range 29-32 % of total fatty acids). Monounsaturated fatty acid content of fish from each of the treatments ranged from 35 % in the initial population sample to 51 % in fish fed the D5 treatment. The proportions of total LC-PUFA in the whole body tissues of the fish fed the treatment diets varied from 10 to 16 %. It was highest in the treatment fed the D20 diet and lowest in the fish fed the D5 diet. However, the initial fish had the highest LC-PUFA content at 23 % of total fatty acids. There was only a minor treatment effect in whole body content of LC-PUFA with increasing DHA inclusion in the diet, even the lowest inclusion level of LC-PUFA (the D1 diet) was relatively conserved at a total LC-PUFA level of 11 % of total fatty acids. There was considerable difference in the fatty acid retention efficiencies of the different PUFA and LC-PUFA. DHA retention efficiency was the most dramatically affected by DHA inclusion level. However, DHA retention efficiency was also improved by the inclusion of EPA (at lower DHA levels; diet D5E), but not by higher inclusion levels of EPA (diet D10E) or the inclusion of ARA in the diet (D10A). At the lowest inclusion level of DHA, the retention efficiency was about 250 %, but as DHA inclusion increased there was a curvilinear decline in retention efficiency such that at the next inclusion level of DHA (D5) retention had declined to around 46 % and by the highest DHA inclusion level (D20) the deposition efficiency had declined to just 28 % (Fig. 1a) .
The retention efficiency of EPA was clearly affected by DHA inclusion level and also by the inclusion of either EPA or ARA in the diet (Fig. 1b) . At the lowest inclusion level of DHA, negative retention efficiencies of EPA were observed. Retention efficiency of EPA increased in a curvilinear fashion with increasing DHA in the diet before declining again to negative deposition efficiency at the highest DHA inclusion. However, among the D10, D10A and D10E diets, there were also marked differences. Addition of ARA reduced EPA deposition efficiency to -18 %, while inclusion of EPA or DHA increased it to 2 or 17 %, respectively. DPA retention efficiency was also affected by DHA inclusion level. However, DPA retention efficiency was also significantly improved by the inclusion of EPA (at EPA inclusion levels; diets D10E and D5E). The inclusion of ARA in the diet (D10A) caused a significant reduction in the retention efficiency of DPA to about 2 %. At the lowest inclusion level of DHA, the retention efficiency of DPA was about 166 %, but with EPA inclusion in the diet the DPA retention efficiency increased to 227 % relative to that achieved with just DHA (D5 and D10), where retention was 23 and 43 % respectively (Fig. 1c) .
In contrast, the deposition efficiencies of ARA, LNA and LOA were largely unaffected by DHA inclusion level. In most cases, there was a consistent level of retention of each of the respective fatty acids. However, the level of retention of each fatty acid varied substantially among each other. ARA retention was generally high at around 165 %, and addition of EPA or ARA to the diet at the 10 g/kg inclusion level reduced ARA retention to around 40 % (Fig. 2a) . The lower inclusion level of EPA had little effect on the efficiency of ARA retention. Retention efficiency of Different superscripts indicate significant differences between means among treatments (P \ 0.05). Lack of a superscript implies that there were no significant differences LNA was also largely unaffected by DHA inclusion level (Fig. 2b) . Although there was some variation in the LNA retention efficiency, there were no consistent patterns in response to DHA dose, or EPA or ARA inclusion. Similarly, deposition efficiency of LOA was also unaffected by DHA inclusion level, or the inclusion of ARA or EPA in the diet (Fig. 2c) .
Plasma chemistry
There were several significant differences among the plasma chemistry parameters relative to dietary treatment (Table 6 ). Only those parameters that showed significant effects that could be attributed to dietary treatment are discussed below.
There was a significant increase in plasma activities of the liver marker enzymes, alanine aminotransferase and asparagine aminotransferase, with the inclusion of ARA in the diet, but varying the levels of DHA or inclusion of EPA had little or no effect on their activities. Although there were significant differences in activity of glutamate dehydrogenase among the treatments, a consistent pattern was not clearly observed. Creatinine levels were not significantly influenced by the level of DHA in the diet, but were significantly affected by the inclusion of ARA or EPA. Plasma calcium levels were significantly different among the treatments with a pattern suggesting a trend towards lower concentrations with increasing dietary DHA. The addition of EPA to the diet increased plasma calcium to significantly greater levels than those in fish fed the equivalent diet with DHA, though addition of ARA did not have the same effect. Plasma cholesterol levels were higher in fish fed the diet D10E. Red blood cell counts showed a significant suppression in the ARA treatment relative to the EPA treatment and also some of the DHA treatments but there did not appear to be a dose response to dietary DHA.
Physical health assessment
A range of physical pathology signs was assessed at week 9 (Table 7) . It was notable that fish fed the low LC-PUFA diet (D1) showed few signs of physical pathologies. Increasing dietary DHA initially increased signs of physical pathology (D5 and D10) but these declined at higher levels (D15 and D20). The only notable effects attributable to EPA or ARA inclusion were increased incidence of pectoral fin erosion (D10E) or scale damage (D10A).
Discussion
The results from the present study provide empirical support of the roles of DHA, EPA or ARA in the diets of Atlantic salmon. The findings of the present study support that, while DHA alone can maintain healthy fish, the addition of EPA to the diet caused a range of physiological and biochemical benefits beyond that achieved using DHA alone. These observations support that EPA also plays an important role in lipid metabolism in this species. Notably, the inclusion of dietary EPA along with DHA promoted better growth and health relative to the low LC-PUFA diet than that achieved by the same level of DHA alone (D10 and/or D20) suggesting distinct roles for each n-3 LC-PUFA. It was also shown that the inclusion of ARA in addition to DHA had little effect on growth, but had some effects on animal health. The observations from the present study in salmon were generally consistent to those reported in a similar study with Asian sea bass (barramundi), although the current study also showed distinct differences, particularly in regards to the clinical observations (Glencross and Rutherford 2011) . These findings raise the question of why such differences between Atlantic salmon and Asian sea bass were observed and whether they relate to the environmental preferences/lifecycle of each species, being anadromous and catadromous, respectively. To address this question, it is pertinent to first consider the effects in relation to previous research in this area to examine why some findings were different and others similar.
It had been reported that the dietary requirement of salmonids for n-3 LC-PUFA was in the range from 10 to 25 g kg -1 of the diet depending on species and experimental conditions (see Glencross 2009 ). The first comprehensive series of studies on fatty acid requirements of a salmonid were those conducted by Castell et al. (1972a, b) with rainbow trout (Oncorhynchus mykiss). In those early studies, fish were fed one of four diets in which treatments included a fat-free diet, a diet in which the 50 g kg -1 lipid in the diet was provided as 18:1n-9, a diet with 40 g kg -1
18:1n-9 and 10 g kg -1 LOA, and a diet with 40 g kg -1 18:1n-9 and 10 g kg -1 LNA. The results Fish Physiol Biochem (2014 ) 40:1213 -1227 1223 of this work demonstrated that salmonids had a defined n-3 requirement, albeit as LNA in this case. However, the value of LNA as an essential nutrient for trout was proposed to exist only because it had significant ability to desaturate and elongate LNA to the biologically active LC-PUFA, EPA and DHA (Tocher 2003) . In the present study, it was interesting to note that the fish fed the D1 diet (albeit not completely devoid of LC-PUFA) showed relatively good survival and growth over a 9-week period of the study. Indeed, classic clinical signs of EFA deficiency were not observed even after 62 days of the experiment. Formative studies by Ruyter et al. (2000a, b) used a series of trials on Atlantic salmon fry in freshwater to determine their quantitative (0, 1, 2, 5, 10 and 20 g kg -1 of the diet) and qualitative requirements for LOA, LNA, and EPA ? DHA in combination. These diets had relatively low lipid levels (*80 g kg -1 ) in which the inclusion of LNA and EPA ? DHA both provided significant benefits to the fish. The combination of EPA ? DHA at 12.5 % total fatty acids provided the greatest benefit of all the treatments studied. While the present data generally support the observations of Ruyter et al. (2000a, b) , the shorter duration of the present study does not allow direct comparison. Codabaccus et al. (2012) also found limited influence of dietary fatty acid composition on growth and feed utilization by post-smolt Atlantic salmon. These authors also examined variations in the ratio of EPA to DHA and found no significant effect on growth or feed utilization. Rainbow trout also grew best with an EPA to DHA ratio of 1:1, but with a total LC-PUFA inclusion level of 3 g kg -1 . However, these authors also reported that EPA could be omitted from the diet and the LC-PUFA supplied solely as DHA to achieve the same effect . Arguably, this might also be possible with Atlantic salmon based on the present results, although the marginal improvements in performance observed with inclusion of both EPA and DHA in the diet suggested both LC-PUFA are probably required.
It has also been reported previously that an excess amount of n-3 LC-PUFA in the diet can have an adverse effect on growth and feed utilization by fish. An increase in EPA or DHA content to four times the proposed requirement level reportedly resulted in poorer growth and feed efficiency, and the fish showed signs similar to EFA deficiency . However, current salmonid diets tend to have lipid levels almost double those used in the 1970s and 1980s. Until the recent increasing dilution of fish oil with alternatives (largely vegetable oils), these diets also had EPA ? DHA inclusion levels considerably above the reported threshold, without the apparent negative effects of inclusion of high amounts of n-3 LC-PUFA Sinnhuber 1976, 1979) . However, several recent studies have demonstrated that high inclusion levels of LC-PUFA can have a significant negative effect on fish performance and health (Ruyter et al. 2000a; Ostbye et al. 2011; Betancor et al. 2011; Glencross and Rutherford 2011) . In the present study, the highest inclusion level of DHA, or a similar LC-PUFA inclusion level of EPA and DHA, did not result in increased levels of physical pathologies, or aberrations in plasma biochemistry or haematology. Different superscripts indicate significant differences between means among treatments (P \ 0.05). Lack of a superscript implies that there were no significant differences
The growth of the fish in the present study, using the pair-fed regime, suggested that the stimulatory effect of DHA was relatively minor. Indeed, although addition of EPA to the diet produced a significant improvement in growth relative to that observed in fish fed the low LC-PUFA diet, the effect was still not as pronounced as that reported in some other species (reviewed by Glencross 2009). However, despite evidence of the importance of dietary EPA in addition to DHA, further exploration of the relationship between the n-3 LC-PUFA and the importance of the ratios between these key PUFA is required (Furuita et al. 1998) .
A potential negative aspect of using a pair-fed feeding regime is that the fish will grow somewhat slower than that expected of fish fed to satiety. However, in the present experiment, the growth rates of the fish were equal to or better than that of Atlantic salmon parr and post-smolt fed to satiety in other recently published works (Miller et al. 2007; Codabaccus et al. 2012) . Indeed, the fish in the present study doubled their weight in 62 days compared with those in the study of Codabaccus et al. (2012) which doubled their weight from 71 to 148 g in 75 days.
The changes in whole body fatty acid composition of fish from each treatment were consistent with those reported in most other studies on fish fed different lipid sources, in that the tissue fatty acids were largely reflective of the respective diets (Sargent et al. 1999) . However, it is the subtleties around the examination of the mass-balance relationship between dietary and tissue fatty acid compositions through the analysis of retention efficiencies that often show distinct differences in the utilization of different dietary fatty acids, particularly in the case of DHA intake (Glencross et al. 2003; Glencross and Rutherford 2011) . However, it should be noted that these observations in the present study were made on a gross nutrient intake basis, not a digestible nutrient intake basis.
The observation that DHA retention efficiency decreased with increasing dietary DHA was consistent with other reports on utilization of this fatty acid (Glencross et al. 2003; Glencross and Rutherford 2011) . At the lowest inclusion level (1 g kg -1 ), the very high deposition efficiency (*250 %) suggested that there was a high degree of conservation and/or possible endogenous synthesis of DHA (Glencross et al. 2003; Turchini and Francis 2009) . Certainly, it is well established that Atlantic salmon have the latter capability Thomassen et al. 2012) . The high levels of DPA retention efficiency combined with the negative retention efficiency values of EPA at low dietary DHA levels support the position that chain elongation and desaturation of precursor fatty acids occurred. However, the pattern of EPA retention efficiency contrasted with that observed in a similar study on Asian sea bass where there was clear retroconversion of DHA to produce EPA (Glencross and Rutherford 2011) . As expected, the addition of EPA to the diet resulted in relatively low deposition efficiency of EPA, but the addition of ARA to the diet produced an even more interesting response in that it also induced a negative deposition efficiency of EPA. This may be attributable to an increase in flux of EPA in the eicosanoid pathways, the activity of which may have been heightened by the additional dietary ARA (Bell et al. 1995; Ghioni et al. 2002) or through increased levels of b-oxidation of this LC-PUFA. Notably, there was some symmetry in EPA retention between the EPA and ARA diets, and this counteractive concentration/response effect has been noted in other species (Xu et al. 2010) . ARA retention in Atlantic salmon was largely unaffected by DHA inclusion, although the addition of EPA or ARA to the diet at the 10 g kg -1 inclusion level resulted in a significant reduction in ARA retention to around 40 %. The absence of any clear dose-response effects of DHA on LNA (or LOA) deposition efficiency suggested that this C18 PUFA appeared to be playing a limited role in DHA supply through possible elongation and desaturation processes. This may be being restricted by the relatively low levels of LNA in the diet (\1 % of total fatty acids).
There have been several reports examining the effects of LC-PUFA (both n-3 and n-6) on the health of fish (Thompson et al. 1996; Rinchard et al. 2007; Ostbye et al. 2011; Betancor et al. 2011) . In the present study, the focus was on both a clinical assessment of physical signs of essential fatty acid deficiency (poor growth, lesions, fin erosion) and also measurement of biochemical markers in plasma. Most notable was the response to dietary ARA as indicated by increased scale damage/skin lesions. The reduction in the level of fin damage with increasing levels of n-3 LC-PUFA was consistent with other studies, although the relatively low levels of fin damage in the low LC-PUFA diet (D1) were perhaps surprising (Castell et al. 1972a, b; Ruyter et al. 2000a) . Fish Physiol Biochem (2014 ) 40:1213 -1227 1225 The plasma biochemical markers provided a more objective assessment of the roles of DHA, EPA and ARA in fish health, and in particular liver function (Glencross and Rutherford 2011) . However, the number of treatments and tests involved meant that significant, but clinically irrelevant, effects may be observed and, therefore, the focus was on effects related to dose response, or relative response to corresponding inclusion of different LC-PUFA. Notably, the present study with Atlantic salmon showed a contrasting result to osmotic balance issues observed previously in Asian sea bass in the relative absence of EPA in the diet (Glencross and Rutherford 2011) . In Atlantic salmon, there was little evidence of perturbations in urea, potassium or chloride levels. This suggested that EPA, which plays an important role in regulating plasma osmolarity through eicosanoid metabolism, was not particularly restricted in this study (Henderson et al. 1985; Beckman and Mustafa 1992) . This could be a sign that EPA requirements for Atlantic salmon were lower than in Asian sea bass or that endogenous biosynthesis was sufficient to maintain homoeostasis.
More notable in the present experiment were the changes in liver enzyme markers such as alanine aminotransferase, which showed an acute response to the presence of ARA, but was less responsive to the inclusion of DHA or EPA. Other liver marker enzymes such as glutamate dehydrogenase, however, also showed a dose response to dietary DHA, while still being increased by ARA inclusion. Inclusion of EPA resulted in a lower level of this enzyme activity in the plasma. These observations provided some support to negative effects of ARA and DHA at high inclusion levels (in the absence of EPA) on the liver health of this species. The addition of EPA to the diet also had a significant effect on plasma cholesterol levels. However, given that diets D10E and D5E were the only ones to have fish oil added to their formulations is difficult to rule out the introduction of this increased cholesterol to the diet via this fish oil addition as driving this effect.
The present study showed that Atlantic salmon were not highly sensitive to dietary LC-PUFA manipulation and could perform relatively well with only low dietary levels of these fatty acids. It was notable that the addition of EPA to the diet resulted in further improvements to growth and feed conversion. However, manipulation of the dietary inclusion of the various LC-PUFA had marked effects on the retention of key fatty acids, and it could be seen that both EPA and ARA played an important role in the retention of DHA and the elongation of EPA to DPA and DHA.
